The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Exact Sciences's share price is $58.79. Exact Sciences's Book Value per Share for the quarter that ended in Dec. 2023 was $17.34. Hence, Exact Sciences's PB Ratio of today is 3.39.
Good Sign:
Exact Sciences Corp stock PB Ratio (=3.39) is close to 1-year low of 3.32
The historical rank and industry rank for Exact Sciences's PB Ratio or its related term are showing as below:
EXAS'
s PB Ratio Range Over the Past 10 Years
Min: 1.69 Med: 6.24 Max: 20.42
Current: 3.39
During the past 13 years, Exact Sciences's highest PB Ratio was 20.42. The lowest was 1.69. And the median was 6.24.
EXAS's PB Ratio is ranked worse than 73.81% of 210
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.065
vs EXAS: 3.39
During the past 12 months, Exact Sciences's average Book Value Per Share Growth Rate was 1.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 7.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 19.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 28.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Exact Sciences was 107.80% per year. The lowest was -45.60% per year. And the median was 7.60% per year.
Back to Basics: PB Ratio
Exact Sciences PB Ratio Historical Data
The historical data trend for Exact Sciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Exact Sciences's PB Ratio
For the Diagnostics & Research subindustry, Exact Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Exact Sciences's PB Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Exact Sciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Exact Sciences's PB Ratio falls into.
Exact Sciences PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Exact Sciences's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Exact Sciences PB Ratio Related Terms
Thank you for viewing the detailed overview of Exact Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Exact Sciences (Exact Sciences) Business Description
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EXAS has been successfully added to your 